First human test of new drug for lung scarring and tumors
NCT ID NCT05740475
Summary
This was the first study in humans to test the safety of an experimental drug called 9MW3811. The trial involved 32 healthy adult volunteers who received either the drug or a placebo. Researchers measured how the body processed the drug and checked for any side effects to determine if it's safe for future testing in patients with pulmonary fibrosis (lung scarring) and cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scientia Clinical Research
Randwick, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.